125 related articles for article (PubMed ID: 36999418)
1. Suppression of mTOR Expression by siRNA Leads to Cell Cycle Arrest and Apoptosis Induction in MDA-MB-231 Breast Cancer Cells.
Sahu R; Jha S; Pattanayak SP
Curr Gene Ther; 2023; 23(3):228-242. PubMed ID: 36999418
[TBL] [Abstract][Full Text] [Related]
2. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
4. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
Saqcena M; Patel D; Menon D; Mukhopadhyay S; Foster DA
Cell Cycle; 2015; 14(14):2285-92. PubMed ID: 25945415
[TBL] [Abstract][Full Text] [Related]
6. [Effects of mammalian-target-of-rapamycin pathway on lapatinib resistance in breast cancer MDA-MB-231 cells].
Wang JD; Wang QS; Bai YZ; Kou DQ; Li XR; Chen L; Li R
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1915-7. PubMed ID: 24124748
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 May; 27(11):. PubMed ID: 35684480
[TBL] [Abstract][Full Text] [Related]
8. HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Cycle; 2016 Oct; 15(19):2585-2592. PubMed ID: 27245202
[TBL] [Abstract][Full Text] [Related]
9. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
[TBL] [Abstract][Full Text] [Related]
10. Effects of RNA interference-mediated silencing of toll-like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF-7 and MDA-MB-231 cells: An in vitro study.
Gao XL; Yang JJ; Wang SJ; Chen Y; Wang B; Cheng EJ; Gong JN; Dong YT; Liu D; Wang XL; Huang YQ; An DD
J Cell Physiol; 2018 Jan; 234(1):433-442. PubMed ID: 29932226
[TBL] [Abstract][Full Text] [Related]
11. Anti-Proliferation and Pro-Apoptotic Effects of Diosmetin via Modulating Cell Cycle Arrest and Mitochondria-Mediated Intrinsic Apoptotic Pathway in MDA-MB-231 Cells.
Wang C; Li S; Ren H; Sheng Y; Wang T; Li M; Zhou Q; He H; Liu C
Med Sci Monit; 2019 Jun; 25():4639-4647. PubMed ID: 31228347
[TBL] [Abstract][Full Text] [Related]
12. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
13. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Wang CD; Yuan CF; Bu YQ; Wu XM; Wan JY; Zhang L; Hu N; Liu XJ; Zu Y; Liu GL; Song FZ
Asian Pac J Cancer Prev; 2014; 15(2):769-73. PubMed ID: 24568493
[TBL] [Abstract][Full Text] [Related]
14. IL-8 protects prostate cancer cells from GSK-3β-induced oxidative stress by activating the mTOR signaling pathway.
Sun Y; Ai JZ; Jin X; Liu LR; Lin TH; Xu H; Wei Q; Yang L
Prostate; 2019 Jul; 79(10):1180-1190. PubMed ID: 31104320
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.
Zhou H; Zheng L; Lu K; Gao Y; Guo L; Xu W; Wang X
Med Sci Monit; 2017 Oct; 23():4817-4825. PubMed ID: 28987049
[TBL] [Abstract][Full Text] [Related]
16. Expression of mTOR and its inhibitory effect on cell proliferation and apoptosis of breast cancer cells.
Cheng XF; Liu Q; Zhang XF; Zhao HD; Wang W; Chu AJ
J Biol Regul Homeost Agents; 2015; 29(4):869-73. PubMed ID: 26753650
[TBL] [Abstract][Full Text] [Related]
17. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract][Full Text] [Related]
18. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
20. The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
Liu H; Zang C; Schefe JH; Schwarzlose-Schwarck S; Regierer AC; Elstner E; Schulz CO; Scholz C; Possinger K; Eucker J
Anticancer Res; 2011 Sep; 31(9):2713-22. PubMed ID: 21868512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
